Malignancies of the Genitourinary Tract

  • Rolf Ackermann
  • Volker Diehl
Conference proceedings

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 126)

Table of contents

  1. Front Matter
    Pages I-XIII
  2. Carcinoma of the Prostate

    1. E. Varenhorst, K. V. Pedersen, P. Carlsson, K. Berglund, O. Löfman
      Pages 25-30
    2. B. J. Schmitz-Dräger, T. Ebert, R. Ackermann
      Pages 31-42
    3. H. G. W. Frohmüller, M. P. Wirth
      Pages 43-49
    4. H. G. W. Frohmüller, M. P. Wirth
      Pages 51-57
    5. R. Berges, H. Schulze, T. Senge
      Pages 59-69
    6. H. Rübben, K. Rembrink, T. Johnston
      Pages 71-88
  3. Renal Cell Carcinoma

    1. M. Marberger, R. Simak
      Pages 89-104
    2. S. D. Boyd, D. G. Skinner, G. Lieskovsky
      Pages 105-111
    3. T. Ebert, B. J. Schmitz-Dräger, R. Ackermann
      Pages 113-118
  4. Superficial Bladder Cancer

  5. Invasive Bladder Cancer

    1. M. Stöckle, F. Steinbach, G. Voges, R. Hohenfellner
      Pages 151-163
    2. S. D. Boyd, D. G. Skinner, G. Lieskovsky
      Pages 165-173
    3. W. U. Shipley, D. S. Kaufman, P. P. Griffin, A. F. Althausen, N. M. Heney, G. R. Prout Jr.
      Pages 207-216
  6. Germ Cell Tumors

    1. J. P. Donohue
      Pages 217-225
    2. K. Colleselli, S. Poisel, W. Schachtner, G. Bartsch
      Pages 227-236
    3. H. I. Scher, D. F. Bajorin, R. J. Motzer, G. J. Bosl
      Pages 257-272
  7. Back Matter
    Pages 273-275

About these proceedings


Malignancies originating from the urogenital tract account for about 20% of all solid neoplasias. The various tumor types, including carcinoma of the prostate, transitional cell carcinoma, renal cell carcinoma, and testicular germ cell tumors, differ widely in terms of biological features, in­ cidence and appearance, diagnostic work-up and manage­ ment. It is not surprising that this complexity of urologic oncology with its related problems has increasingly attracted both experimental investigators and clinical experts. Only time will tell whether the achievements that today are con­ sidered· as progress will turn out to be significant contribu­ tions towards the ultimate goal: the cure of the patients' life-threatening diseases with little or no side effects. How­ ever, many innovations and improvements have already taken place in the field of urologic oncology within recent years. The high pace of innovative development requires continuous, thorough, and critical updating of our kowledge so that persisting deficits can be defined: the basic require­ ment for posing new scientific questions. The following examples may serve to illustrate the recent developments and the resulting new problems and questions: Recently, it has become evident that carcinoma of the prostate must be detected earlier to enable us to cure more of the affected patients in the future than currently.


DNA Staging adjuvant therapy cancer carcinoma cell chemotherapy cystectomy cytokines oncology prostate prostatectomy renal cell carcinoma screening urology

Editors and affiliations

  • Rolf Ackermann
    • 1
  • Volker Diehl
    • 2
  1. 1.Urologische KlinikHeinrich-Heine-UniversitätDüsseldorfGermany
  2. 2.Medizinische Klinik IUniversität KölnKöln 41Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1993
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-84585-7
  • Online ISBN 978-3-642-84583-3
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology